Nxera Pharma and Shionogi Launch QUVIVIQ in Japan for Adults with Insomnia
December 18, 2024 21:35 ET | Source: Nxera Pharma Tokyo, Japan and…
Longer-term data for Novartis Scemblix reinforce superior efficacy with favorable safety and tolerability profile in adults with newly diagnosed CML
Scemblix demonstrated sustained superior major molecular response (MMR) vs. all investigator-selected TKIs…
Worldwide English Proficiency Index Reports Persistent Global Decline With Weaker Skills in Women and Young adults
ZURICH, Nov. 13, 2024 /PRNewswire/ -- EF Education First (EF), a global provider of…
